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Regarding “A randomized trial of carotid artery
stenting with and without cerebral protection”
Barbato and colleagues1 are to be congratulated on perform-
ing the first randomized trial comparing carotid artery stenting
(CAS) with and without the use of a filter-type cerebral protection
device. Although their results do not support the common notion
that cerebral protection devices reduce the number of embolic
events occurring during CAS, several points of concern arise with
respect to the conduct of the trial, patient selection and data
analysis.
On the basis of a retrospective analysis of non-randomized
data with all its inherent limitations, we recently demonstrated that
the use of protection devices significantly reduces the incidence of
new diffusion-weighted imaging (DWI) lesions after CAS (propor-
tion of patients with any new ipsilateral DWI lesion, 67% in those
treated without vs 49% in those treated with protection devices;
P  0.05) and that approximately 120 to 140 patients would be
needed for a randomized trial on the basis of these data.2 As already
pointed out by the authors, this trial therefore fell far short of a
sample size that would be sufficient to detect a significant differ-
ence between both treatment modalities. More importantly, sub-
group analyses of our data set have indicated that the beneficial
effect of protection devices in preventing the occurrence of new
DWI lesions might not pertain to older and asymptomatic pa-
tients.3 The negative findings of this trial could thus very well be
based on the high number of asymptomatic patients as well as old
patients. Along the way it should be noted that a minor or major
stroke rate of 13% in asymptomatic patients is unacceptably high,
indicating that the majority of patients included in this trial would
have been better off with medical treatment alone.
In the past few years, evidence has accumulated that certain
anatomic features, including a severe vessel tortuosity or aortic arch
abnormalities, are associated with an increased periprocedural
complication rate during CAS despite the use of cerebral protec-
tion devices.4,5 Despite the small patient number, a technical
failure rate of 11% in the cerebral protection group stresses the
importance of excluding these patients from any future trial.
Irrespective of these limitations, we definitely concur with
Barbato and colleagues that further randomized trials of unpro-
tected versus protected CAS using DWI as an additional surrogate
end point should be expedited. Ideally, these trials should include
only patients with a symptomatic carotid stenosis, who are younger
than 70 years of age.
Andreas Kastrup, MD
Sonja Schnaudigel, MD
Klaus Gröschel, MD
Department of Neurology
University of Göttingen
Göttingen, Germany
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Reply
We read with interest the thoughtful letter to the editor of
Kastrup et al and agree with most of the voiced comments, in
particular the recommendation that additional investigation of the
assumed salutory effects of distal protection filters should be un-
dertaken. Our study was significantly underpowered to answer the
question in a meaningful manner, and serves only to underscore
our lack of understanding of the potential drawbacks of routine
filter use during carotid artery stenting (CAS).
We are familiar with the authors’ study referred to in the letter,
showing findings quite different from ours in the frequency of
diffusion-weighted magnetic resonance imaging lesions among
patients treated with protected or unprotected CAS. We agree that
age and symptomatic status explain many of the differences be-
tween the two reports, but the retrospective studymethodology, as
well as the multitude of filters used with different crossing profiles
may have also influenced the findings. For example, their most
commonly used filter crosses the lesion as a simple wire, which may
be related to a lower incidence of noted microemboli. In addition,
the use of filters as well as the performance of magnetic resonance
imaging studies in their review did not follow specific indications,
introducing a selection bias that further complicates the compari-
son of our two studies.
Although we agree with Kastrup’s comments regarding the
lack of benefit of asymptomatic octogenarians from interventional
treatment in general and CAS in particular, care must be taken to
avoid the use of our clinical outcomes in a very limited dataset to
support or refute that contention. A larger review we previously
published agrees with the opinions presented in the letter.1 Our
current manuscript, however, which includes only a fraction of our
total experience, does not shed any additional light on the topic.
Michel S. Makaroun, MD
University of Pittsburgh
Pittsburgh, Pa
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Regarding “Aortic neck dilatation after endovascular
abdominal aortic aneurysm repair: A word of
caution”
Congratulations to Drs Diehm, Dick, Katzen, Schumidli,
Kalka, and Baumgartner for their review article focusing on the
phenomenon of neck dilation after endovascular abdominal aortic
aneurysm repair.1 However, this review did not include a study we
recently conducted and published in the Journal of Endovascular
Therapy.2 This study concludes with valuable results because it
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